Li Yong

Li Yong

Lawyer

Member of the Science and Technology Innovation and Industrial Chain Legal Services Committee of the Jiangsu Provincial Lawyers Association

Member of the Biopharmaceutical and Health Industry Special Committee of the Nanjing Lawyers Association 
Member of the Securities, Futures, and Fund Law Committee of the Nanjing Lawyers Association

 

Principal Consulting Office

  • Jinling Pharmaceutical Co., Ltd. (stock code: 000919)
  • Laishen Tongling Jewelry Co., Ltd. (Stock Code: 603900)
  • Zhejiang Wansheng Co., Ltd. (Stock Code: 603010)
  • Baosheng Technology Innovation Co., Ltd. (Stock Code: 600973)
  • Jiangsu Phoenix Real Estate Investment Co., Ltd. (Stock Code: 600716)
  • Jiangsu BeitaiFu Medical Technology Co., Ltd.
  • Jiangsu Huineng Clean Energy Co., Ltd.
  • Nanjing Second Architectural Design Institute Co., Ltd.

Contact Information

Contact phone number:

18602545428

Fax number:

025-84505533

Email:

liyong@jcmaster.com

License Number:

13201201610597174

Business Domain

Securities issuance and listing, corporate restructuring and reorganization, investment and financing, and compliance management for listed companies

Professional Experience

June 2012: Graduated from the School of Law, Nanjing University, with a Master of Laws degree. 
April 2016 to present:  Attorney, JC Master Law Office

Typical Cases

  • Nanjing University Environmental Planning and Design Research Institute Co., Ltd. (ChiNext Board of the Shenzhen Stock Exchange, stock code: 300864) IPO project; 2021 Restricted Stock Incentive Plan (Class II) project
  • Zhejiang Wansheng Co., Ltd. (Shanghai Stock Exchange Main Board, stock code: 603010), Project for the 2026 Restricted Stock Incentive Plan (Class I), and Investment Due Diligence Office
  • Yadong Group’s Main Board Listing Project on the Stock Exchange of Hong Kong
  • Jinling Pharmaceutical Co., Ltd. (Shenzhen Stock Exchange Main Board, stock code: 000919) has undertaken a share issuance to specific investors, including the acquisition of Siyang County People’s Hospital, Suzhou Zhongmei Coal Mine Construction General Hospital, Huzhou Social Welfare Center Co., Ltd., Chizhou Dongsheng Pharmaceutical Co., Ltd., and Nanjing Meishan Hospital Limited Liability Company, as well as an equity transfer project involving Nanjing Huadong Pharmaceutical Co., Ltd., along with the 2021 Restricted Stock Equity Incentive Plan (Type I).
  • Baosheng Technology Innovation Co., Ltd. (Shanghai Stock Exchange Main Board, stock code: 600973) – Non‑public issuance of A‑shares and the first phase of its employee stock ownership plan.
  • Laishen Tongling Jewelry Co., Ltd. (Shanghai Stock Exchange Main Board, stock code: 603900) – 2017 Stock Option Plan and 2022 Restricted Stock Incentive Plan (Class I) Project
  • Equity Incentive Project of Nanjing Kati Medical Technology Co., Ltd. (Unlisted)
  • Dispute over a Sales Contract Case Involving Jiangsu Haizhi Biopharmaceutical Co., Ltd.
  • Special Liquidation of Jiangsu Tongning Hetai Real Estate Co., Ltd.
  • Equity Financing Project of Jiangsu Huazhang Intelligent Technology Co., Ltd.
  • Jiayuan International Residential Purchase Balance Asset-Backed Securities Project
  • Public Transport Revenue Rights Asset Securitization Project of Taizhou Transportation Industry Group Co., Ltd.
  • Nanjing Design Institute of China Gezhouba Group Power Co., Ltd. has acquired the photovoltaic project of Beijing Jinyige (Jiuquan) New Energy Technology Co., Ltd.
  • Jiangsu Spruce Clean Energy Investment Holding Co., Ltd. has acquired the Xinxin Dantu 60 MW agrivoltaic power station, the Fengyang Xinxin 20 MW agrivoltaic power station, the Taizhou Gangyang Town 60 MW agrivoltaic photovoltaic project, and the Inner Mongolia Hangjin Banner 200 MW wind–storage integrated demonstration project.
  • China Cinda Asset Management Co., Ltd. Jiangsu Branch has extended a entrusted loan to Zhuhai Hengqin National Development Investment Co., Ltd.